07971459383

KETHAN PHARMA DISTRIBUTORS
GST : 36ABMPO2384G1ZD

Our Products

Pharmaceutical Tablets

Pharmaceutical Injection

Pharmaceutical Capsules

Anti Cancer Injection

Mircera 50 Mcg Injection

Therapy Lotion

Cardiovascular Injection

Recombinant Tissue Plasminogen Activator For Injection 20 Mg Kit

Pharmaceutical Cream

Mouth Freshener Spray

X-Wet Saliva Supplement Mouth Spray

Oral Suspension

Megestrol Acetate Oral Suspension USP

Pharmaceutical Syrup

Curcuage Liquid

Erlotinib Tablets IP 150 Mg

Name: Erlotinib Tablets IP 150 Mg
Brand: KETHAN PHARMA DISTRIBUTORS
Price: 9502 INR
Availability: InStock

Price 9502 INR/ Pack

Get a Price/Quote

MOQ : 1 Pack

Erlotinib Tablets IP 150 Mg Specification

Packaging Type
Box

Pacakaging (Quantity Per Box)
30 tablets

Dosage Form
Tablet

Origin of Medicine
India

Indication
Non-small cell lung cancer, pancreatic cancer

Brand Name
Erlocip

Life Span
2 years

Salt Composition
Erlotinib

Drug Type
Allopathic

Ingredients
Erlotinib

Physical Form
Tablet

Function
Cancer Treatment

Recommended For
Anti-cancer therapy

Dosage
150 mg

Dosage Guidelines
As directed by physician

Suitable For
Adults

Quantity
30 tablets

Storage Instructions
Store below 30C

Prescription Requirement
Yes

Usage
Once daily

Main Category
Antineoplastic agent

Color
White

Schedule
Prescription only drug

Strength
150 mg

Route of Administration
Oral

Shape
Oval

Erlotinib Tablets IP 150 Mg Trade Information

Minimum Order Quantity
1 Pack

Payment Terms
Cash in Advance (CID)

Supply Ability
1000 Packs Per Month

Delivery Time
7 Days

Main Domestic Market
All India

About Erlotinib Tablets IP 150 Mg

Erlotinib Tablets IP 150 Mg, marketed as Erlocip, are an elite choice in anti-cancer therapy, celebrated for their optimum effectiveness. Formulated with 150 mg of Erlotinib, these white, oval tablets are administered orally, once daily, strictly under physician guidance. Indicated for the treatment of non-small cell lung cancer and pancreatic cancer, Erlocip promises brilliance in targeted cancer care. With limited-time savings for bulk and scheduled orders, this allopathic medicine-available in a box pack of 30-delivers trust, reliability, and cost-efficiency for adult patients seeking celebrated results.

Targeted Cancer Solution: Optimum Use & Application

Erlotinib Tablets IP 150 Mg are specifically used as an antineoplastic agent for adults requiring treatment for non-small cell lung cancer or pancreatic cancer. These oral oval-shaped tablets provide a targeted approach to cancer therapy, administered once daily as per physician guidance. Used exclusively under medical prescription, Erlocip is indicated for systemic application, offering a precise, controlled dosage for optimum patient benefits in anti-cancer care.

Elite Markets & Premier Supply Channels

Erlotinib Tablets IP 150 Mg are widely supplied throughout the main domestic market of India and exported to celebrated international destinations. The robust packaging ensures quality throughout expenditure and distribution, with each box containing 30 tablets. As a leading exporter, supplier, and trader, sample quantities are available on request, facilitating efficient evaluation and procurement for bulk or ongoing clinical use. Experience timely delivery and optimum packaging for global medical requirements.

FAQ's of Erlotinib Tablets IP 150 Mg:

Q: How should Erlotinib Tablets IP 150 Mg be used for best results?

A: Erlotinib Tablets IP 150 Mg should be taken orally, once daily, following the exact dosage and instructions provided by your physician to ensure optimum therapeutic benefits and minimize side effects.

Q: What is the primary indication for Erlotinib Tablets IP 150 Mg?

A: These tablets are primarily indicated for the treatment of non-small cell lung cancer and pancreatic cancer in adults, as prescribed by a qualified healthcare professional.

Q: Where is Erlotinib Tablets IP 150 Mg available and who supplies it?

A: Erlotinib Tablets IP 150 Mg is available across India and is also supplied to prominent international markets by reliable exporters, suppliers, and traders specializing in pharmaceutical products.

Q: What are the storage instructions for these tablets?

A: Store Erlotinib Tablets IP 150 Mg in a cool, dry place below 30C, within its original packaging, to maintain its efficacy throughout its two-year shelf life.

Q: When should a patient consider taking Erlotinib Tablets IP 150 Mg?

A: This medication should only be considered under a doctor's recommendation after a confirmed diagnosis of non-small cell lung cancer or pancreatic cancer and suitability for this specific therapy.

Q: What are the main benefits of using Erlotinib Tablets IP 150 Mg?

A: The tablets offer a targeted and celebrated therapeutic option for cancer treatment, featuring trusted efficacy, easy oral administration, and consistent dosage, making them a brilliant choice for eligible patients.